Form 4: Itron Director Timothy Leyden Receives Quarterly Equity Compensation Grant
Insider Transaction Report
Itron, Inc. Director Timothy M. Leyden was granted 150 shares of common stock on July 1, 2025, as part of his quarterly board compensation, increasing his total beneficial ownership to 15,390 shares.
Summary
- Timothy M. Leyden, a Director of Itron, Inc. (ITRI), acquired 150 shares of common stock.
- The transaction occurred on July 1, 2025.
- The shares were granted at a price of $0, indicating they were part of his quarterly compensation for board service.
- Following this acquisition, Mr. Leyden beneficially owns a total of 15,390 shares of Itron common stock.
- Mr. Leyden deferred the receipt of 56 shares of the granted common stock pursuant to Itron's Executive Deferred Compensation Plan.
Sentiment
Score: 7
Explanation: The document reports a routine equity compensation grant to a director, which is a positive sign of alignment between management and shareholders, but does not contain significant new financial or strategic information that would drastically alter sentiment.
Positives
- Director Timothy M. Leyden received 150 shares of Itron common stock as part of his compensation, which aligns his interests with those of shareholders.
- The grant increases Mr. Leyden's total beneficial ownership to 15,390 shares, demonstrating continued insider stake in the company.
Future Outlook
NA
Management Comments
- The grant reflects common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service.
- Mr. Leyden deferred receipt of 56 shares pursuant to Itron's Executive Deferred Compensation Plan.
Industry Context
NA
Related Party Transactions
- Grant of 150 shares of common stock to Director Timothy M. Leyden as part of his quarterly compensation for board service.
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholders due to increased equity ownership.
Key Dates
| Date | Description |
|---|---|
| 07/01/2025 | Date of common stock grant to Director Timothy M. Leyden. |
| 07/02/2025 | Date the Form 4 was signed by Christopher E. Ware, attorney-in-fact for Timothy M. Leyden. |
Keywords
Itron, ITRI, Timothy Leyden, Director Compensation, Equity Grant, SEC Form 4, Insider Ownership, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.